132 followers
1-5-2021: In a study released today from Taipei, Taiwan, Actemra (tocilizumab) helped a very sick 53-year old man recover from COVID-19. However, researchers also used many other treatments so I can't count this as Taiwan's 1st pro-Actemra COVID-19 study